Isracann Biosciences Inc. announced the appointments of Dr. George Vrabec to the position of Director of Natural Health Products in connection with the Transaction. The appointments will take effect as of April 15, 2022. Dr. George Vrabec, MD FRCSC (Urol.) is a Urologist and Surgeon with over 20 years of medical experience, as well as the Principal Investigator of Exdeo Clinical Research.

Dr. Vrabec has conducted more than 30 clinical trials in a wide array of Urological diseases and has published studies in various journals, including the New England Journal of Medicine. Dr. Vrabec serves on multiple boards, including Fraser Valley Health Care Foundation.